Aberdeen Group’s Avalyn Pharma AVLN Stock Holding History

Aberdeen Group’s Portfolio AVLN Stock Details AVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21M	Buy	+67,174	New	+$1.94M	﹤0.01%	766

Other funds holding AVLN

Andera Partners Paris $206M AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Aberdeen Group's AVLN Position: Q2 2026 in Review

Aberdeen Group opened a new position in Avalyn Pharma (AVLN) in Q2 2026: 67,174 shares worth $2.21M. The stake represents ﹤0.01% of the portfolio and ranks #766 among its holdings.

11 funds tracked by Wall St. Rank hold AVLN as of Q2 2026.

Aberdeen Group held 67,174 shares of Avalyn Pharma worth $2.21M as of Q2 2026.
Avalyn Pharma was a new Aberdeen Group position in Q2 2026.
Avalyn Pharma made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #766 holding.
11 funds tracked by Wall St. Rank held Avalyn Pharma as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.